BamSEC and AlphaSense Join Forces
Learn More

Crescent Biopharma Inc. – Transcripts

NASDAQ: CBIO    
Share price (9/21/26): $16.25    
Market cap (9/21/26): $604 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
M&A Revised 10/29/24 GlycoMimetics, Inc. - M&A Call 10/29/24
Other Revised 06/27/24 GlycoMimetics, Inc. - Special Call 06/04/24
Earnings Revised 05/07/24 GlycoMimetics, Inc., Q1 2024 Earnings Call, May 06, 2024 05/06/24
Earnings Revised 03/27/24 GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 03/27/24
CY 2023
Earnings Revised 11/03/23 GlycoMimetics, Inc., Q3 2023 Earnings Call, Nov 03, 2023 11/03/23
Earnings Revised 08/02/23 GlycoMimetics, Inc., Q2 2023 Earnings Call, Aug 02, 2023 08/02/23
Earnings Revised 05/04/23 GlycoMimetics, Inc., Q1 2023 Earnings Call, May 03, 2023 05/03/23
Earnings Revised 03/29/23 GlycoMimetics, Inc., Q4 2022 Earnings Call, Mar 29, 2023 03/29/23
CY 2022
Earnings Revised 11/09/22 GlycoMimetics, Inc., Q3 2022 Earnings Call, Nov 09, 2022 11/09/22
Earnings Revised 08/03/22 GlycoMimetics, Inc., Q2 2022 Earnings Call, Aug 03, 2022 08/03/22
Earnings Revised 07/26/24 GlycoMimetics, Inc., Q1 2022 Earnings Call, Apr 28, 2022 04/28/22
Earnings Revised 03/03/22 GlycoMimetics, Inc., Q4 2021 Earnings Call, Mar 03, 2022 03/03/22
CY 2021
Earnings Revised 11/02/21 GlycoMimetics, Inc., Q3 2021 Earnings Call, Nov 02, 2021 11/02/21
Earnings Revised 08/05/21 GlycoMimetics, Inc., Q2 2021 Earnings Call, Aug 05, 2021 08/05/21
Other Revised 05/18/21 GlycoMimetics, Inc. - Shareholder/Analyst Call 05/18/21
Earnings Revised 05/03/21 GlycoMimetics, Inc., Q1 2021 Earnings Call, May 03, 2021 05/03/21
Earnings Revised 03/02/21 GlycoMimetics, Inc., Q4 2020 Earnings Call, Mar 02, 2021 03/02/21
CY 2020
Other Revised 11/19/20 GlycoMimetics, Inc. Presents at Jefferies 2020 Virtual London Healthcare Conference, Nov-19-2020 06:45 PM 11/19/20
Other Revised 11/17/20 GlycoMimetics, Inc. Presents at 2020 Stifel Virtual Healthcare Conference, Nov-17-2020 08:00 AM 11/17/20
Earnings Revised 11/06/20 GlycoMimetics, Inc., Q3 2020 Earnings Call, Nov 06, 2020 11/06/20
Earnings Revised 07/31/20 GlycoMimetics, Inc., Q2 2020 Earnings Call, Jul 31, 2020 07/31/20
Other Revised 05/22/20 GlycoMimetics, Inc. - Shareholder/Analyst Call 05/22/20
Earnings Revised 05/01/20 GlycoMimetics, Inc., Q1 2020 Earnings Call, May 01, 2020 05/01/20
Earnings Revised 02/28/20 GlycoMimetics, Inc., Q4 2019 Earnings Call, Feb 28, 2020 02/28/20
CY 2019
Earnings Revised 11/07/19 GlycoMimetics, Inc., Q3 2019 Earnings Call, Nov 07, 2019 11/07/19
Other Revised 09/11/19 GlycoMimetics, Inc. Presents at Morgan Stanley 17th Annual Global Healthcare Conference, Sep-11-2019 01:35 PM 09/11/19
Earnings Revised 08/01/19 GlycoMimetics, Inc., Q2 2019 Earnings Call, Aug 01, 2019 08/01/19
Earnings Revised 05/02/19 GlycoMimetics, Inc., Q1 2019 Earnings Call, May 02, 2019 05/02/19
Earnings Revised 03/06/19 GlycoMimetics, Inc., Q4 2018 Earnings Call, Mar 06, 2019 03/06/19
CY 2018
Other Revised 12/03/18 GlycoMimetics, Inc. - Shareholder/Analyst Call 12/03/18
Earnings Revised 11/02/18 GlycoMimetics, Inc., Q3 2018 Earnings Call, Nov 02, 2018 11/02/18
Earnings Revised 08/10/18 GlycoMimetics, Inc., Q2 2018 Earnings Call, Aug 10, 2018 08/10/18
Earnings Revised 05/03/18 GlycoMimetics, Inc., Q1 2018 Earnings Call, May 03, 2018 05/03/18
Earnings Revised 03/06/18 GlycoMimetics, Inc., Q4 2017 Earnings Call, Mar 06, 2018 03/06/18
CY 2017
Other Revised 12/19/17 GlycoMimetics, Inc. - Special Call 12/19/17
Earnings Revised 11/08/17 GlycoMimetics, Inc., Q3 2017 Earnings Call, Nov 08, 2017 11/08/17
Earnings Revised 05/18/17 GlycoMimetics, Inc., Q1 2017 Earnings Call, May 18, 2017 05/18/17